RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price ...

RBC Capital analyst Chris Dendrinos maintained a Buy rating on HASI (HASI – Research Report) yesterday and set a price target of $38.00. The ...

RBC Capital Markets adjusted its price target for Q2 Holdings stock, raising it to $108 from the previous $105, while maintaining a Sector Perform rating. The increase follows Q2 Holdings' report of ...

Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

RBC Capital raised the firm’s price target on Aptiv (APTV) to $82 from $75 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company’s guidance is “even more ...

It expresses the views and opinions of the author. A leading global investment bank and part of Royal Bank of Canada, RBC Capital Markets is recognized for its commitment to innovation ...

State of Alaska Department of Revenue lifted its position in RBC Bearings Incorporated (NYSE:RBC – Free Report) by 5.8% in ...